vs
Side-by-side financial comparison of Invivyd, Inc. (IVVD) and NATIONAL BANKSHARES INC (NKSH). Click either name above to swap in a different company.
Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $15.3M, roughly 1.1× NATIONAL BANKSHARES INC). NATIONAL BANKSHARES INC runs the higher net margin — 38.5% vs -64.3%, a 102.8% gap on every dollar of revenue. On growth, NATIONAL BANKSHARES INC posted the faster year-over-year revenue change (24.7% vs 24.5%).
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
IVVD vs NKSH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.2M | $15.3M |
| Net Profit | $-11.1M | $5.9M |
| Gross Margin | — | — |
| Operating Margin | -73.0% | 47.4% |
| Net Margin | -64.3% | 38.5% |
| Revenue YoY | 24.5% | 24.7% |
| Net Profit YoY | 40.0% | 91.0% |
| EPS (diluted) | $0.02 | $0.93 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.2M | $15.3M | ||
| Q3 25 | $13.1M | $14.2M | ||
| Q2 25 | $11.8M | $13.3M | ||
| Q1 25 | $11.3M | $12.8M | ||
| Q4 24 | $13.8M | $12.2M | ||
| Q3 24 | $9.3M | $11.7M | ||
| Q2 24 | $2.3M | $10.9M | ||
| Q1 24 | $0 | $10.4M |
| Q4 25 | $-11.1M | $5.9M | ||
| Q3 25 | $-10.5M | $4.4M | ||
| Q2 25 | $-14.7M | $2.3M | ||
| Q1 25 | $-16.3M | $3.2M | ||
| Q4 24 | $-18.4M | $3.1M | ||
| Q3 24 | $-60.7M | $2.7M | ||
| Q2 24 | $-47.2M | $-307.0K | ||
| Q1 24 | $-43.5M | $2.2M |
| Q4 25 | -73.0% | 47.4% | ||
| Q3 25 | -84.0% | 37.9% | ||
| Q2 25 | -127.8% | 20.0% | ||
| Q1 25 | -149.7% | 30.5% | ||
| Q4 24 | -139.1% | 30.1% | ||
| Q3 24 | -670.0% | 27.5% | ||
| Q2 24 | -2175.2% | -4.4% | ||
| Q1 24 | — | 25.8% |
| Q4 25 | -64.3% | 38.5% | ||
| Q3 25 | -79.7% | 31.1% | ||
| Q2 25 | -124.4% | 17.2% | ||
| Q1 25 | -144.1% | 25.3% | ||
| Q4 24 | -133.5% | 25.1% | ||
| Q3 24 | -653.1% | 22.8% | ||
| Q2 24 | -2086.9% | -2.8% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | $0.02 | $0.93 | ||
| Q3 25 | $-0.06 | $0.69 | ||
| Q2 25 | $-0.12 | $0.36 | ||
| Q1 25 | $-0.14 | $0.51 | ||
| Q4 24 | $-0.14 | $0.50 | ||
| Q3 24 | $-0.51 | $0.42 | ||
| Q2 24 | $-0.40 | $-0.05 | ||
| Q1 24 | $-0.38 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $226.7M | $59.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $241.5M | $184.9M |
| Total Assets | $276.9M | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $226.7M | $59.3M | ||
| Q3 25 | $85.0M | $42.3M | ||
| Q2 25 | $34.9M | $92.8M | ||
| Q1 25 | $48.1M | $122.5M | ||
| Q4 24 | $69.3M | $108.1M | ||
| Q3 24 | $106.9M | $49.8M | ||
| Q2 24 | $147.9M | $98.9M | ||
| Q1 24 | $189.4M | $121.2M |
| Q4 25 | $241.5M | $184.9M | ||
| Q3 25 | $93.1M | $179.2M | ||
| Q2 25 | $42.8M | $168.7M | ||
| Q1 25 | $54.1M | $167.3M | ||
| Q4 24 | $67.5M | $156.4M | ||
| Q3 24 | $83.2M | $167.8M | ||
| Q2 24 | $140.6M | $149.0M | ||
| Q1 24 | $178.5M | $139.4M |
| Q4 25 | $276.9M | $1.8B | ||
| Q3 25 | $139.2M | $1.8B | ||
| Q2 25 | $89.1M | $1.8B | ||
| Q1 25 | $103.7M | $1.8B | ||
| Q4 24 | $129.5M | $1.8B | ||
| Q3 24 | $161.9M | $1.8B | ||
| Q2 24 | $177.3M | $1.8B | ||
| Q1 24 | $215.5M | $1.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.5M | $17.9M |
| Free Cash FlowOCF − Capex | — | $15.2M |
| FCF MarginFCF / Revenue | — | 99.2% |
| Capex IntensityCapex / Revenue | 0.0% | 17.9% |
| Cash ConversionOCF / Net Profit | — | 3.04× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.5M | $17.9M | ||
| Q3 25 | $-8.3M | $6.1M | ||
| Q2 25 | $-13.3M | $2.1M | ||
| Q1 25 | $-21.1M | $2.6M | ||
| Q4 24 | $-37.6M | $9.4M | ||
| Q3 24 | $-41.1M | $3.1M | ||
| Q2 24 | $-41.6M | $-3.0M | ||
| Q1 24 | $-50.2M | $3.8M |
| Q4 25 | — | $15.2M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | $-13.3M | $1.5M | ||
| Q1 25 | $-21.3M | $1.6M | ||
| Q4 24 | $-37.6M | $6.2M | ||
| Q3 24 | $-41.1M | $2.2M | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | $-50.4M | $3.5M |
| Q4 25 | — | 99.2% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | -112.9% | 11.5% | ||
| Q1 25 | -188.2% | 12.5% | ||
| Q4 24 | -272.2% | 50.5% | ||
| Q3 24 | -441.6% | 18.5% | ||
| Q2 24 | — | -36.3% | ||
| Q1 24 | — | 33.8% |
| Q4 25 | 0.0% | 17.9% | ||
| Q3 25 | 0.0% | 5.6% | ||
| Q2 25 | 0.1% | 4.1% | ||
| Q1 25 | 1.3% | 7.5% | ||
| Q4 24 | 0.0% | 26.6% | ||
| Q3 24 | 0.1% | 8.3% | ||
| Q2 24 | 0.0% | 9.3% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | 3.04× | ||
| Q3 25 | — | 1.38× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.79× | ||
| Q4 24 | — | 3.07× | ||
| Q3 24 | — | 1.17× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
